DNA's 41st Annual Convention
  • Home
  • About
    • Experience
    • About Convention
    • Contact Us
    • Hotel Info
  • Schedule
    • Monday
    • Tuesday
    • Wednesday
    • Thursday
    • NP Forum
  • Speakers
  • Exhibit Hall
  • Registration
  • Thursday
    7:00 am – 8:00 am

    Coffee Service/Muffins

    Room: 200/201/202
      
    8:00 am – 9:00 am

    Invisible Danger: The Implications of “Forever Chemicals” to Dermatologic Disease

    General Session 310: Invisible Danger: The Implications of “Forever Chemicals” to Dermatologic Disease
    Room: Chatham C
    Participants will learn the history, origin, routes of exposure and health implications of PFAS with an emphasis on dermatology. Learning Objectives: Describe PFAS, its chemical attributes and history of development. Describe sources of exposure and potential health consequences. Identify agencies and groups that are sources of up-to-date mitigation strategies and patient education.
    Dede Sullivan, PhD, APRN-BC, NP-C /   
    9:00 am – 9:15 am

    Break

      
    9:15 am – 10:15 am

    Understanding Clinical Trials

    General Session 320: Understanding Clinical Trials
    Room: Chatham C
    Will discuss basic trial designs, review examples of cutting edge clinical trials, understand future clinical trial platforms. Learning Objectives: Understand the basics of study design. Describe the components of a clinical trial. Describe keys to success.
    Aaron Mangold, MD, FAAD /   
    10:15 am – 11:15 am

    Pearls of Writing for Publication

    General Session 330: Pearls of Writing for Publication Room: Chatham C The presentation will cover the pearls of writing for publication, including how to choose a journal, choose a subject, identify the scope of your article, format of your article, how to start writing, the basics of scholarly writing, choosing references, what to expect from the peer review process, and resources available to authors through the JDNA. Learning Objectives: Identify 3 evidence-based barriers to publication for nurses and mitigation strategies. Identify at least 3 resources available to them through the JDNA to assist with drafting a manuscript. Define what a collaborative mentor is and the importance of engaging other clinical staff.
    Sylvana Brickley, DCNP /   
    11:30 am – 1:00 pm

    Business/Awards Lunch Meeting

      
    1:15 pm – 2:15 pm

    Skin Cancer After Organ Transplant

    General Session 350: Skin Cancer After Organ Transplant Room: Chatham C Overview of the risk for skin cancer in patient's with organ transplantation. This will bring awareness to the importance in counseling this patient population in practice about maintenance and management as well as multidisciplinary care. Learning Objectives: Understand the risk of skin cancer after organ transplantation and detecting risk factors.
    Elizabeth May Hayward, MSN, CRNP, AGPCNP-BC, DNCP, CWCN & Naomi Y. Hur, MSN, CRNP, AGACNP-BC /   
    2:15 pm – 3:15 pm

    Cutaneous Manifestations of Monkey Pox

    General Session 360: Cutaneous Manifestations of Monkey Pox Room: Chatham C This presentation describes the cutaneous manifestations of Monkeypox in order to guide early and accurate diagnosis. Therapeutic options will also be discussed. Learning Objectives: Understand the epidemiology of the virus. Understand the transmission and clinical presentation of the current outbreak of monkeypox. Understand treatment and prevention options.
    Heli Patel, B.S. /   
    3:15 pm – 3:30 pm

    Break

      
    3:30 pm – 4:30 pm

    Procedural Transgender Care in Dermatology

    General Session 370: Procedural Transgender Care in Dermatology Room: Chatham C This presentation will explore the use of lasers for transgender care in dermatology including the use of lasers preoperatively and postoperatively. Conditions such as scarring, surgical prep, and overall promotion of gender affirming care in dermatology will be discussed.
    Heather Onoday, FNP-C, DCNP /   
    4:30 pm – 5:30 pm

    Melanoma: Diagnosis and Management

    General Session 380: Melanoma: Diagnosis and Management Room: Chatham C This presentation will include a review of the diagnosis of melanoma including biopsy techniques as well as the management of dysplastic nevi and melanoma. Learning Objectives: Review statistics of cutaneous melanoma and other types. Identify uncommon subtypes of melanoma. Identify risk factors, diagnostics, and management of uncommon types. Review how Gene Expression Profiling can be useful in clinical practice.
    Mary Nolen, MS, ANP-BC, DCNP /   
    © 2022 - 2023, Dermatology Nurses' Association. All Rights Reserved. Site hosted and developed by Convergent Systems, LLC